IP Library › Granted Patent US 10,405,571
Granted Patent B2
US 10,405,571 · App. 15/192,480 · Granted Sep 10, 2019

Compositions and methods for producing tobacco plants and products having altered alkaloid levels

Inventors: Andrew Carl Adams (Midlothian, VA); Marcos Fernando de Godoy Lusso (Chesterfield, VA); Sreepriya Pramod (Glen Allen, VA); Dongmei Xu (Glen Allen, VA)
Assignee: Altria Client Services LLC
A24B15/10A01H5/12A24B3/12A24B13/00A24B13/02A24D1/045A24D3/043C12N15/8243
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,405,571
App. No.
15/192,480
Granted
Sep 10, 2019
Kind
B2
Abstract

The present disclosure provides the identification of tobacco Nic1 locus. Also provided are tobacco plants with altered total alkaloid and nicotine levels and commercially acceptable leaf grade, their development via breeding or transgenic approaches, and production of tobacco products from these tobacco plants. Also provided are compositions and methods for producing tobacco plants having novel Nic1 mutations or alleles to reduce nicotine levels. Further provided are sequence polymorphisms and molecular markers for breeding tobacco with reduced nicotine or nicotine free while maintaining tobacco leaf grade and tobacco product quality.

Claims (20)

1. A tobacco plant, or part thereof, comprising a first polymorphism in SEQ ID NO: 131 and a second polymorphism in SEQ ID NO: 137, wherein said tobacco plant comprises nicotine at a level below 25% of the nicotine level of a control plant when grown in similar growth conditions, wherein said tobacco plant is capable of producing leaves that, when cured, have a USDA grade index value of at least about 65% of the USDA grade index value of leaves of said control plant when grown and cured in similar conditions, wherein said control plant shares an essentially identical genetic background with said tobacco plant except said first and second polymorphisms, wherein said first polymorphism comprises an A nucleotide at the polymorphic site of SEQ ID NO:131, and wherein said second polymorphism comprises a C nucleotide at the polymorphic site of SEQ ID NO: 137.

2. The tobacco plant, or part thereof, of claim 1 , wherein said tobacco plant is capable of producing leaves that, when cured, have a USDA grade index value of 50 or more.

3. The tobacco plant, or part thereof, of claim 1 , wherein said tobacco plant comprises nicotine at a level below 15% of the nicotine level of said control plant when grown in similar growth conditions.

4. The tobacco plant, or part thereof, of claim 1 , wherein said tobacco plant comprises a nicotine level less than 2.0%.

5. Cured tobacco material from the tobacco plant, or part thereof, comprising a first polymorphism in SEQ ID NO:131 and a second polymorphism in SEQ ID NO:137, wherein said tobacco plant comprises nicotine at a level below 25% of the nicotine level of a control plant when grown in similar growth conditions, wherein said tobacco plant is capable of producing leaves that, when cured, have a USDA grade index value of at least about 65% of the USDA grade index value of leaves of said control plant when grown and cured in similar conditions, wherein said control plant shares an essentially identical genetic background with said tobacco plant except said first and second polymorphisms, wherein said first polymorphism comprises an A nucleotide at the polymorphic site of SEQ ID NO: 131, and wherein said second polymorphism comprises a C nucleotide at the polymorphic site of SEQ ID NO: 137; wherein said cured tobacco material comprises said first polymorphism and said second polymorphism.

6. The cured tobacco material of claim 5 , wherein said cured tobacco material comprises a lower level of nicotine compared to cured tobacco material from said control tobacco plant.

7. The cured tobacco material of claim 5 , wherein said tobacco plant comprises nicotine at a level between 0.2% and 0.6%.

8. The cured tobacco material of claim 5 , wherein said cured tobacco material is made by a curing process selected from the group consisting of flue curing, air curing, fire curing, and sun curing.

9. A tobacco product comprising the cured tobacco material of claim 5 .

10. The tobacco product of claim 9 , wherein said tobacco product is selected from the group consisting of a cigarette, a cigarillo, a non-ventilated recess filter cigarette, a vented recess filter cigarette, a cigar, snuff, pipe tobacco, cigar tobacco, cigarette tobacco, chewing tobacco, leaf tobacco, shredded tobacco, and cut tobacco.

11. The tobacco product of claim 9 , wherein said tobacco product is a smokeless tobacco product.

12. The tobacco plant, or part thereof, of claim 1 , wherein said tobacco plant is not a flue-cured tobacco.

13. The tobacco plant, or part thereof, of claim 1 , wherein said tobacco plant is a flue-cured tobacco.

14. The tobacco plant, or part thereof, of claim 1 , wherein said tobacco plant is a burley tobacco.

15. The tobacco plant, or part thereof, of claim 1 , wherein said tobacco plant is an oriental tobacco.

16. The tobacco plant, or part thereof, of claim 1 , wherein said tobacco plant is an air-cured tobacco.

17. The tobacco plant, or part thereof, of claim 1 , wherein said tobacco plant is a fire-cured tobacco.

18. The tobacco plant, or part thereof, of claim 1 , wherein said tobacco plant comprises nicotine at a level below 8% of the nicotine level of said control plant when grown in similar growth conditions.

19. The tobacco plant, or part thereof, of claim 1 , wherein said first polymorphism comprises an A nucleotide at the polymorphic site of SEQ ID NO: 131 and a G nucleotide at the polymorphic site of SEQ ID NO: 136.

20. The tobacco plant, or part thereof, of claim 1 , wherein said second polymorphism comprises a C nucleotide at the polymorphic site of SEQ ID NO: 137 and a C nucleotide at the polymorphic site of SEQ ID NO: 142.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 11, 2017
From: ADAMS, ANDREW CARL; DE GODOY LUSSO, MARCOS FERNANDO; PRAMOD, SREEPRIYA; XU, DONGMEI
To: ALTRIA CLIENT SERVICES LLC
Reel/Frame 044356/0599 →
Continuity (5)
Provisional Application 62335772 · May 13, 2016
Provisional Application 62271780 · Dec 28, 2015
Provisional Application 62186854 · Jun 30, 2015
Provisional Application 62185268 · Jun 26, 2015
Related Publication 20160374387A1 · Dec 29, 2016
Cited By (3)
US 12,575,536 US 12,725,248 US 12,742,174